We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Recordati S.p.A. SWOT Analysis report provides you a strategic analysis ...

Industries: Drug and Medication | Countries: Czech Republic, Italy, Europe

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • October 2014
  • 109 pages

BMI View: Our expectations that the Czech Republic would return to moderately positive growth in 2011, before seeing negligible growth in 2012 have been revised downwards, and we now project very low growth for the current year as well as 2012. Despite this downward revision, BMI maintains that relatively ...

Industries: Drug and Medication | Countries: Czech Republic

Gilead Sciences, Inc. (GILD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Gilead Sciences, Inc. (GILD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 95 pages

Summary Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company. The company undertakes the discovery, development and commercialization of innovative medicines in areas of unmet medical need. The product and pipeline portfolio of the company focuses on various therapeutic areas ...

Industries: Drug and Medication | Countries: United States, Canada, World, North America, Czech Republic

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • July 2014
  • 112 pages

BMI View: In response to the expected passage of key drug policy reforms in the Czech Republic, BMI has cut its projections for pharmaceutical industry growth in 2012 to 0.0%, with the prospects of lower prices, difficult industry entry and increased generic substitution the major contributing factors. ...

Industries: Drug and Medication | Countries: Czech Republic

NRT Smoking Cessation Aids in the Czech Republic

NRT Smoking Cessation Aids in the Czech Republic

  • $ 898
  • Industry report
  • by Euromonitor International
  • June 2014
  • 19 pages

While the number of smokers in the Czech Republic remains relatively stable, more and more consumers are pledging to give up smoking. Out of those who do, only approximately 20% of them succeed in quitting smoking. Czechs are starting to smoke at a younger age and smoking is very common at secondary ...

Industries: Drug and Medication, Tobacco | Countries: Czech Republic

Analgesics Market Analysis in the Czech Republic

Analgesics Market Analysis in the Czech Republic

  • $ 898
  • Industry report
  • by Euromonitor International
  • June 2014
  • 22 pages

The Analgesics in Czech Republic report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the segments driving growth. It identifies the leading firms , the leading brands and offers strategic ...

Industries: Drug and Medication | Countries: Czech Republic

Cough, Cold and Allergy (Hay Fever) Remedies in the Czech Republic

Cough, Cold and Allergy (Hay Fever) Remedies in the Czech Republic

  • $ 898
  • Industry report
  • by Euromonitor International
  • June 2014
  • 26 pages

Cough, cold and allergy (hay fever) remedies was the largest consumer health category in 2013, reaching current value sales of CZK3.1 billion. Coughs and colds are common recurring illnesses in the Czech Republic and the self-medication of consumers, combined with an inability to complete the necessary ...

Industries: Drug and Medication | Countries: Czech Republic

Gilead Sciences, Inc. (Symbol:GILD) SWOT Analysis, Strategy, Revenues and Profits

Gilead Sciences, Inc. (Symbol:GILD) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • April 2014
  • 55 pages

Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutic drugs in unmet medical need areas. The product portfolio of the company is focused on various therapeutic areas such as antivirals, cardiovascular conditions and respiratory ...

Industries: Drug and Medication | Countries: Czech Republic, India, Europe

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • April 2014
  • 104 pages

Includes 3 FREE quarterly updates BMI View: We retain our negative outlook for the pharmaceutical industry in the Czech Republic, expecting a 1.8% contraction in its value in local currency terms in 2012, following the 1.0% year-onyear (y-o-y) decrease calculated for 2011. While the increase in the value-added ...

Industries: Drug and Medication | Countries: Czech Republic

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 1 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • January 2014
  • 101 pages

The Czech Republic retains its pole position in BMI’s Q111 Regional Business Environment Ratings (BERs) for Emerging Europe. In our global table, the Czech Republic moved upward, placing 12th, now being sandwiched between Germany above and the United Arab Emirates (UAE) below. However, significant ...

Industries: Drug and Medication | Countries: Czech Republic

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.